Altered Glycosylation in the Aging Heart

Patricia Franzka1, Lynn Krüger2,3, Mona K Schurig1

  • 1Institute of Human Genetics, University Hospital Jena, Friedrich Schiller University, Jena, Germany.

Insights

Aging hearts show increased high-mannose N-glycans, a common protein modification. These changes in the cardiac glycoproteome may contribute to age-related cardiovascular decline.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Aging Research

Background:

  • Cardiovascular disease is a leading cause of death, with aging as a primary risk factor.
  • Aged hearts exhibit cardiac hypertrophy, fibrosis, and inflammation, but molecular mechanisms remain unclear.
  • Protein glycosylation, a key post-translational modification, influences protein function and biological properties.

Purpose of the Study:

  • To investigate age-related changes in the cardiac glycoproteome.
  • To identify specific alterations in protein glycosylation patterns in the aging heart.
  • To explore the functional implications of these glycomic changes on cardiovascular health.

Main Methods:

  • Analysis of cardiac glycoproteome in mice of different ages.
  • Western blot and MALDI-TOF based glycome analysis.
  • Quantitative mass spectrometry of cardiac glycoproteins.

Main Results:

  • A significant increase in high-mannose N-glycans was observed with aging.
  • Age-related regulation of GMPPB, an enzyme involved in GDP-mannose supply, was identified.
  • Widespread alterations in cardiac glycoproteins were detected, particularly in extracellular matrix and Ca2+-binding proteins.

Conclusions:

  • The study provides the first comprehensive analysis of the aging cardiac glycoproteome.
  • Age-associated changes in glycosylation, especially high-mannose N-glycans, are evident in the heart.
  • Alterations in the cardiac glycoproteome are proposed to contribute to age-related cardiovascular functional decline.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.2K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
43
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
39
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
56